These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 26722288)

  • 1. Expression of secreted phospholipase A2-Group IIA correlates with prognosis of gastric adenocarcinoma.
    Zhang C; Yu H; Xu H; Yang L
    Oncol Lett; 2015 Nov; 10(5):3050-3058. PubMed ID: 26722288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of inflammatory secretory phospholipase A2 and cytosolic phospholipase A2 in premalignant and malignant Barrett's oesophagus.
    Lagorce-Pagès C; Paraf F; Wendum D; Martin A; Fléjou JF
    Virchows Arch; 2004 May; 444(5):426-35. PubMed ID: 15045585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum secretory phospholipase A2-IIa (sPLA2-IIA) levels in patients surviving acute myocardial infarction.
    Xin H; Chen ZY; Lv XB; Liu S; Lian ZX; Cai SL
    Eur Rev Med Pharmacol Sci; 2013 Apr; 17(8):999-1004. PubMed ID: 23661511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical role of phospholipase A2 isoforms in advanced-stage ovarian carcinoma.
    Gorovetz M; Baekelandt M; Berner A; Trope' CG; Davidson B; Reich R
    Gynecol Oncol; 2006 Dec; 103(3):831-40. PubMed ID: 16919315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of group IIA secretory phospholipase A2 is elevated in prostatic intraepithelial neoplasia and adenocarcinoma.
    Jiang J; Neubauer BL; Graff JR; Chedid M; Thomas JE; Roehm NW; Zhang S; Eckert GJ; Koch MO; Eble JN; Cheng L
    Am J Pathol; 2002 Feb; 160(2):667-71. PubMed ID: 11839587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Group IIa secretory phospholipase A2 (sPLA2IIa) and progression in patients with lung cancer.
    Wang M; Hao FY; Wang JG; Xiao W
    Eur Rev Med Pharmacol Sci; 2014; 18(18):2648-54. PubMed ID: 25317799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secretory phospholipase A2-IIa is a target gene of the HER/HER2-elicited pathway and a potential plasma biomarker for poor prognosis of prostate cancer.
    Oleksowicz L; Liu Y; Bracken RB; Gaitonde K; Burke B; Succop P; Levin L; Dong Z; Lu S
    Prostate; 2012 Jul; 72(10):1140-9. PubMed ID: 22127954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma secretory phospholipase A2-IIa as a potential biomarker for lung cancer in patients with solitary pulmonary nodules.
    Kupert E; Anderson M; Liu Y; Succop P; Levin L; Wang J; Wikenheiser-brokamp K; Chen P; Pinney SM; Macdonald T; Dong Z; Starnes S; Lu S
    BMC Cancer; 2011 Dec; 11():513. PubMed ID: 22151235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diverse cellular localizations of secretory phospholipase A2 enzymes in several human tissues.
    Masuda S; Murakami M; Ishikawa Y; Ishii T; Kudo I
    Biochim Biophys Acta; 2005 Oct; 1736(3):200-10. PubMed ID: 16188494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of group IIa secretory phospholipase A2 increases with prostate tumor grade.
    Graff JR; Konicek BW; Deddens JA; Chedid M; Hurst BM; Colligan B; Neubauer BL; Carter HW; Carter JH
    Clin Cancer Res; 2001 Dec; 7(12):3857-61. PubMed ID: 11751475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of Secretory Phospholipase A2 Group IIa in Breast Cancer and Correlation to Prognosis in a Cohort of Advanced Breast Cancer Patients.
    Jespersen SS; Stovgaard ES; Nielsen D; Christensen TD; Buhl ASK; Christensen IJ; Balslev E
    Appl Immunohistochem Mol Morphol; 2021 Jan; 29(1):e5-e9. PubMed ID: 32217848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated Type II Secretory Phospholipase A2 Increases the Risk of Early Atherosclerosis in Patients with Newly Diagnosed Metabolic Syndrome.
    Sun CQ; Zhong CY; Sun WW; Xiao H; Zhu P; Lin YZ; Zhang CL; Gao H; Song ZY
    Sci Rep; 2016 Dec; 6():34929. PubMed ID: 27941821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phospholipase A2 in chamber angle of normal eyes and patients with primary open angle glaucoma and exfoliation glaucoma.
    Rönkkö S; Rekonen P; Kaarniranta K; Puustjarvi T; Teräsvirta M; Uusitalo H
    Mol Vis; 2007 Mar; 13():408-17. PubMed ID: 17417602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Helicobacter infection and phospholipase A2 enzymes: effect of Helicobacter felis-infection on the expression and activity of sPLA2 enzymes in mouse stomach.
    Ottlecz A; Romero JJ; Lichtenberger LM
    Mol Cell Biochem; 2001 May; 221(1-2):71-7. PubMed ID: 11506189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Labour is associated with increased expression of type-IIA secretory phospholipase A2 but not type-IV cytosolic phospholipase A2 in human myometrium.
    Slater DM; Astle S; Bennett PR; Thornton S
    Mol Hum Reprod; 2004 Nov; 10(11):799-805. PubMed ID: 15361552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Group IIA secretory phospholipase 2 independently predicts mortality and positive blood culture in emergency department sepsis patients.
    Nandi U; Jones AE; Puskarich MA
    J Am Coll Emerg Physicians Open; 2021 Jun; 2(3):e12460. PubMed ID: 34179883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma levels of phospholipase A2-IIA in patients with different types of malignancies: prognosis and association with inflammatory and coagulation biomarkers.
    Menschikowski M; Hagelgans A; Schuler U; Froeschke S; Rosner A; Siegert G
    Pathol Oncol Res; 2013 Oct; 19(4):839-46. PubMed ID: 23722320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secretory type II phospholipase A2 is produced and secreted by epicardial adipose tissue and overexpressed in patients with coronary artery disease.
    Dutour A; Achard V; Sell H; Naour N; Collart F; Gaborit B; Silaghi A; Eckel J; Alessi MC; Henegar C; Clément K
    J Clin Endocrinol Metab; 2010 Feb; 95(2):963-7. PubMed ID: 20008021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin II type 1-receptor antagonism prevents type IIA secretory phospholipase A2-dependent lipid peroxidation.
    Luchtefeld M; Bandlow N; Tietge UJ; Grote K; Pfeilschifter J; Kaszkin M; Beck S; Drexler H; Schieffer B
    Atherosclerosis; 2007 Sep; 194(1):62-70. PubMed ID: 17069818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vav3 oncogene is involved in regulation of secretory phospholipase A2-IIa expression in prostate cancer.
    Dong Z; Liu Y; Levin L; Oleksowicz L; Wang J; Lu S
    Oncol Rep; 2011 Jun; 25(6):1511-6. PubMed ID: 21455584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.